Adjuvant Therapy for Renal Cell Carcinoma

被引：5
|
作者：
Pinto, Alvaro [1 ]
机构：
[1] Univ Hosp La Paz IdiPAZ, Dept Med Oncol, Madrid 28046, Spain
来源：
CLINICAL GENITOURINARY CANCER | 2014年 / 12卷 / 06期
关键词：
Clinical trials; Immune therapy; Relapse risk; Risk reduction; Targeted therapy; POSTOPERATIVE PROGNOSTIC NOMOGRAM; RADICAL NEPHRECTOMY; PHASE-III; HIGH-RISK; STAGE-II; RANDOMIZED-TRIAL; CANCER; INTERFERON; RECURRENCE; SURVIVAL;
D O I：
10.1016/j.clgc.2014.06.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In the past few years, several targeted therapies have been approved by the U.S. Food and Drug Administration for the treatment of advanced renal cell carcinoma. This has led to an improvement in the progression-free survival and quality of life for these patients. Nevertheless, the use of these and other therapies in the adjuvant setting has failed to demonstrate a clear benefit. Immune therapies and hormonal or targeted therapies have been studied in this indication, and there are clinical trials currently enrolling patients with high risk of relapse. This article reviews the available data and the ongoing trials exploring the role of adjuvant therapy for kidney cancer.
引用
收藏
页码：408 / 412
页数：5
相关论文
共 50 条
  • [41] Adjuvant therapy for high-risk renal cell carcinoma patients
    Kunkle D.A.
    Haas N.B.
    Uzzo R.G.
    [J]. Current Urology Reports, 2007, 8 (1) : 19 - 30
  • [42] Adjuvant therapy in renal-cell carcinoma: Is it prime time yet?
    Dimitriadis, John
    Bamias, Aristotelis
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S360 - S362
  • [43] Adjuvant Therapy in Renal Cell Carcinoma: Current Status and Future Directions
    Kazarian, Austin G.
    Chawla, Neal S.
    Muddasani, Ramya
    Pal, Sumanta K.
    [J]. KIDNEY CANCER, 2021, 5 (01) : 9 - 20
  • [44] Adjuvant therapy with activated T cells for patients with renal cell carcinoma
    LeFever, A
    Treisman, J
    Hanson, J
    [J]. JOURNAL OF IMMUNOTHERAPY, 2003, 26 (06): : S20 - S21
  • [45] Adjuvante Therapiestrategien beim NierenzellkarzinomStrategies for adjuvant therapy in renal cell carcinoma
    C. Doehn
    [J]. Der Onkologe, 2008, 14 (10): : 1065 - 1070
  • [46] Adjuvant Therapy for Resected Renal Cell Carcinoma-Still Searching
    Wood, Lori
    [J]. EUROPEAN UROLOGY, 2018, 74 (05) : 621 - 622
  • [47] Adjuvant therapy options in renal cell carcinoma — targeting the metastatic cascade
    Kelly N. Fitzgerald
    Robert J. Motzer
    Chung-Han Lee
    [J]. Nature Reviews Urology, 2023, 20 : 179 - 193
  • [48] Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectives
    Larroquette, Mathieu
    Peyraud, Florent
    Domblides, Charlotte
    Lefort, Felix
    Bernhard, Jean-Christophe
    Ravaud, Alain
    Gross-Goupil, Marine
    [J]. CANCER TREATMENT REVIEWS, 2021, 97
  • [49] Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascade
    Fitzgerald, Kelly N.
    Motzer, Robert J.
    Lee, Chung-Han
    [J]. NATURE REVIEWS UROLOGY, 2023, 20 (03) : 179 - 193
  • [50] Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options
    Lam, JS
    Leppert, JT
    Belldegrun, AS
    Figlin, RA
    [J]. BJU INTERNATIONAL, 2005, 96 (04) : 483 - 488
12345